About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD28.45
- USD28.78
- USD27.17
- USD44.32
- -4.80%
- 9M
- 1.68M
- 1.60M
- 4.7B
- 12.75
- 93.30%
Stock News
2 hours ago
Former Boeing CEO and Seattle Mariners co-owner Frank Shrontz dies aged 92
Yahoo
3 hours ago
How previous investing mistakes are shaping my thinking on the latest stock gone wrong
CNBC
3 hours ago
Is Boeing Stock a Buy?
Yahoo
3 hours ago
Should You Buy ChargePoint While More Money Is Going Out Than Coming In?
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
